文献速递胸部肿瘤

残障人士肺癌诊断与治疗中的差异

Disparities in the Diagnosis and Treatment of Lung Cancer among People with Disabilities.
PubMed 文献 · J Thorac Oncol · 2018-11-16

该回顾性队列研究利用韩国国民健康服务数据库、残障登记数据和韩国中央癌症登记数据,纳入13,591例残障肺癌患者和43,809例年龄性别匹配的无残障对照。结果显示残障患者接受手术、化疗和放疗的可能性更低,总死亡率略高,尤其在严重残障患者中。作者认为沟通和脑/精神残障患者的不平等诊疗提示存在不合理的残障相关障碍,需要解决。

要点

  • 严重残障患者未知分期更常见(13.1% vs 10.3%),沟通残障14.2%、精神/认知残障15.7%。
  • 残障患者接受手术aOR=0.82、化疗aOR=0.80、放疗aOR=0.92,均低于无残障者。
  • 严重沟通障碍者手术aOR=0.46、化疗aOR=0.64;严重脑/精神障碍者手术aOR=0.39、化疗aOR=0.47、放疗aOR=0.49。

核心结论

  • 残障肺癌患者,尤其严重残障者,接受分期检查和治疗的比例更低,尽管其治疗结局仅略差于无残障者。
  • 作者认为部分差异可能源于合理的临床判断,但沟通和脑/精神残障患者的不平等诊疗提示存在不合理的残障相关障碍,需要解决。

研究设计与样本

  • 回顾性队列研究,链接韩国国民健康服务数据库、残障登记数据和韩国中央癌症登记数据。
  • 纳入13,591例残障肺癌患者和43,809例年龄、性别匹配的无残障肺癌对照。

主要发现

  • 严重残障患者未知分期比例为13.1%,无残障者为10.3%;沟通残障者未知分期14.2%,精神/认知残障者15.7%。
  • 残障患者接受手术的aOR=0.82(95%CI 0.77-0.86),化疗aOR=0.80(95%CI 0.77-0.84),放疗aOR=0.92(95%CI 0.88-0.96)。
  • 严重沟通障碍者手术aOR=0.46,化疗aOR=0.64;严重脑/精神障碍者手术aOR=0.39,化疗aOR=0.47,放疗aOR=0.49。
  • 残障患者总死亡率略高于无残障者,调整后HR=1.08(95%CI 1.06-1.11);严重残障组HR=1.20(95%CI 1.16-1.24)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Potential disparities in the diagnosis, treatment, and survival of patients with lung cancer with and without disabilities have rarely been investigated. METHODS: We conducted a retrospective cohort study with a data set linking the Korean National Health Service database, disability registration data, and Korean Central Cancer Registry data. A total of 13,591 people with disabilities in whom lung cancer had been diagnosed and 43,809 age- and sex-matched control subjects in whom lung cancer had been diagnosed were included. RESULTS: Unknown stage was more common in people with severe disabilities (13.1% versus 10.3%), especially those with a communication (14.2%) or mental/cognitive disability (15.7%). People with disabilities were less likely to undergo a surgical procedure (adjusted OR [aOR] = 0.82, 95% confidence interval [CI]: 0.77-0.86), chemotherapy (aOR = 0.80, 95% CI: 0.77-0.84), or radiotherapy (aOR = 0.92, 95% CI: 0.88-0.96). This higher likelihood was more evident for people with severe communication impairment (aORs of 0.46 for surgery and 0.64 for chemotherapy) and severe brain/mental impairment (aORs 0.39 for surgery, 0.47 for chemotherapy, and 0.49 for radiotherapy). Patients with disabilities had a slightly higher overall mortality than did people with no disability (adjusted hazard ratio = 1.08, 95% CI: 1.06-1.11), especially in the group with a severe disability (a hazard ratio = 1.20, 95% CI: 1.16-1.24). CONCLUSIONS: Patients with lung cancer and disabilities, especially severe ones, underwent less staging work-up and treatment even though their treatment outcomes were only slightly worse than those of people without a disability. Although some degree of disparity might be attributed to reasonable clinical judgement, unequal clinical care for people with communication and brain/mental disabilities suggests unjustifiable disability-related barriers that need to be addressed.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Shin DW, Cho JH, Noh JM, et al. Disparities in the Diagnosis and Treatment of Lung Cancer among People with Disabilities. J Thorac Oncol. 2018. PMID: 30453082. doi:10.1016/j.jtho.2018.10.158

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。